National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM.
| From | National Institutes of Health |
|---|---|
| Who can apply | state governments, counties, cities and townships, special districts (water, fire, parks, etc.), school districts, public colleges and universities and 9 more types |
| Eligibility notes | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or… |
| How much | up to $500K per award; $500K total |
| Deadline | Thu, Jan 7, 2027 (76 days left) |
| Category | Education, Health |
| Type | Grant |
| Opportunity # | PAR-25-081 |
| Assistance listing | 93.393, 93.394, 93.395, 93.399 |
| Posted | Tue, Nov 12, 2024 |